🇺🇸 FDA
Patent

US 12410170

2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds

granted A61KA61K45/06A61P

Quick answer

US patent 12410170 (2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds) held by Arcus Biosciences, Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K45/06, A61P, A61P35/00